Related Experiment Video

Updated: Mar 15, 2026

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection
04:11

Author Spotlight: Advancements and Challenges in Hepatitis B Virus Detection

Published on: December 15, 2023

5.0K

Predictors of Liver Disease Severity in Children with Chronic Hepatitis B

Maria Pokorska-Śpiewak1,2, Barbara Kowalik-Mikołajewska1,2, Małgorzata Aniszewska1,2

  • 1Department of Children's Infectious Diseases, Medical University of Warsaw, Poland.

Advances in Clinical and Experimental Medicine : Official Organ Wroclaw Medical University
|September 16, 2016
PubMed

Insights

Liver histology evaluation is crucial for pediatric chronic hepatitis B (CHB) management. Liver biopsies reveal significant changes, with AST levels better predicting fibrosis than ALT.

Area of Science:

  • Pediatric Hepatology
  • Viral Hepatitis Research
  • Gastroenterology

Background:

  • Liver histology evaluation is essential for managing pediatric chronic hepatitis B (CHB).
  • Understanding histopathological features in children with CHB is critical for effective treatment strategies.

Purpose of the Study:

  • To analyze histopathological features in children diagnosed with CHB.
  • To compare these histological findings with existing clinical and laboratory data.

Main Methods:

  • The study included 30 treatment-naïve children with CHB.
  • Liver biopsies were assessed using the modified Knodell score.
  • Histopathological data were correlated with clinical and laboratory parameters, including HBeAg status, viral load, and liver enzymes.

Main Results:

  • Histopathology showed mild to severe necroinflammatory activity and fibrosis, regardless of HBeAg status, viral load, or infection duration.
  • Alanine aminotransferase (ALT) and aspartate aminotransferase (AST) levels correlated with necroinflammatory activity.
  • Elevated AST levels were associated with more advanced fibrosis, suggesting AST as a potential predictor.

Conclusions:

  • Pediatric CHB patients exhibit diverse liver changes over time.
  • Liver biopsy remains a valuable tool for assessing disease severity in pediatric CHB.
  • Clinical and laboratory markers, including ALT and AST, show limited predictive value for fibrosis, though AST may indicate advanced fibrosis.
Abstract

Keywords:
childrenchronic hepatitisgrading and staginghepatitis B virusliver biopsy

More Related Videos

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection10:25

"Liver-on-a-Chip" Cultures of Primary Hepatocytes and Kupffer Cells for Hepatitis B Virus Infection

Published on: February 19, 2019

12.3K
A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia09:12

A Mouse Model of Chronic Liver Fibrosis for the Study of Biliary Atresia

Published on: February 3, 2023

3.4K

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
248
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
310
Diseases of the Liver and Gallbladder01:26

Diseases of the Liver and Gallbladder

Liver and gallbladder diseases are a significant health concern, with prominent conditions including cirrhosis, hepatitis, non-alcoholic fatty liver disease (NAFLD), and gallstones. Jaundice is a common manifestation of liver and biliary disease.
Cirrhosis is characterized by the scarring of hepatic lobules in the liver, which are replaced by fibrous tissue, affecting the liver's normal functioning. NAFLD, on the other hand, is caused by an excessive build-up of fat in the liver, not...
2.2K
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug01:14

Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug

In pharmacotherapy, monitoring drug concentrations is paramount, especially for drugs whose therapeutic effects hinge on both the active compound and its metabolite. Hepatic impairment profoundly influences drug potency by altering liver function. If the drug is more potent than its metabolite, impaired liver function amplifies drug activity due to elevated drug concentration levels. Conversely, if the metabolite holds greater potency, diminished liver function diminishes drug activity by...
277
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
312
Hepatic Drug Excretion: Influencing Factors01:16

Hepatic Drug Excretion: Influencing Factors

The biliary system of the liver, crucial for bile secretion and drug excretion, comprises intrahepatic bile ducts that merge to form the common hepatic duct. This duct, carrying hepatic bile, combines with the cystic duct, draining the gallbladder and forming the common bile duct, which empties into the duodenum. Bile, produced by hepatic cells lining the bile canaliculi, is composed primarily of water, bile salts, pigments, electrolytes, and lesser amounts of cholesterol and fatty acids. Bile...
704